Definium Therapeutics, Inc. (DFTX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-15, first reflected in a filing dated 2022-11-10. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

89.33M
Year ended 2025-12-31
+42.5%
3-year compound annual growth
2021-12-31: 27.38M2022-12-31: 30.86M2023-12-31: 39.16M2024-12-31: 70.46M2025-12-31: 89.33M89.33M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3189.33M+26.8%2026-02-26, From 2025-01-01
2024-12-3170.46M+79.9%2026-02-26, From 2024-01-01
2023-12-3139.16M+26.9%2025-03-06, From 2023-01-01
2022-12-3130.86M+12.7%2024-02-28, From 2022-01-01
2021-12-3127.38Mn/a2023-03-09, From 2021-01-01